Josh Schimmer
Josh Schimmer is a financial analyst at Cantor Fitzgerald, known for his insights into market trends and company valuations, particularly in the healthcare sector. He has gained attention for his outspoken views on the implications of political decisions on the pharmaceutical industry, especially following the controversial appointment of Robert F. Kennedy Jr. as Secretary of Health under the Trump administration, which he criticized for undermining scientific integrity.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 5.00 | 0.04% | +0% | 46,754,778 | 19,862 | $1,400,000 | 595$ |
| Totals | 1 | 46,754,778 | 19,862 | $1,400,000 | 595$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Spain:
Josh Schimmer is an analyst at Cantor Fitzgerald who criticized the leadership change in the FDA under Kennedy.
5